North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report By Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), By End Use (Hospitals, Homecare), By Country, And Segment Forecasts,
Published Date: May - 2025 | Publisher: MIR | No of Pages: 250 | Industry: healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2999 Download Sample Ask for Discount Request CustomizationMarket Size & Trends
The size of the North America syringe infusion pumps market was valued at USD 645.1 million in 2024 and is expected to grow at a CAGR of 8.4% during the period 2025-2035. The growth of the market in the region is primarily due to the increasing incidence of chronic diseases such as cancer, cardiovascular disease, diabetes, and respiratory disease. These conditions require exact, uninterrupted drug delivery, which syringe infusion pumps enable by making it possible to deliver accurate doses of life-critical drugs like chemotherapy drugs and insulin. Since an estimated six out of ten North American adults are affected by at least one chronic disorder, the need for dependable infusion devices in hospitals and ambulatory care facilities continues to rise, highlighting the critical role these pumps play in managing patients.
The rising demand for surgeries and intensive care unit (ICU) admissions contributes largely to the growth of the syringe infusion pump market. Syringe infusion pumps play a critical role in the critical care setting, providing accurate dosages of anesthetics, analgesics, and vasoactive agents during surgeries and treating critically ill patients. As per a Washington Post report published in March 2025, U.S. hospitalizations per year are projected to rise from 36 million in 2025 to 40 million in 2035, further driving the need for reliable infusion devices that provide correct delivery of medication.
The advancement of smart infusion technologies through technological innovations is also imperative in driving market growth. The capabilities of DERS, wireless technology, and electronic health record (EHR) compatibility make the infusion systems safer and more efficient in terms of drug administration. Since North America is ahead in embracing advanced infusion systems, healthcare professionals enjoy enhanced compliance with protocols and fewer medication errors, improving clinical decision-making and patient safety.
Home care and ambulatory care expansion have driven increasing needs for portable, easy-to-use syringe pumps driven by an aging population and cost-containment initiatives. Syringe infusion pumps allow safe delivery of medication beyond the confines of hospital environments, drastically enhancing patient outcomes and quality of life. In combination with favorable regulatory and reimbursement policies, these market conditions provide continued growth and innovation across the North American region.
Report Coverage & Deliverables
PDF report & online dashboard will help you understand
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Disease Indication Insights
Pediatrics/neonatology was the market leader and held a revenue share of 26.5% in 2024. The increased number of births, with preterm and low-birth-weight babies, has caused greater dependency on specialty infusion devices. Improvements in smart pump systems, with capabilities of Dose Error Reduction Systems and EMR connectivity, have minimized medication errors. Increased investment in PICUs and NICUs, in addition to rigorous safety protocols, has continued to highlight the imperative role played by syringe infusion pumps in the provision of safe, quality care to at-risk pediatric populations.
Chemotherapy will grow at the highest CAGR of 9.7% during the forecast period. Syringe infusion pumps have a vital role in oncology practice by maintaining accuracy and precision in drug delivery, especially in chemotherapy drugs with narrow therapeutic indexes. Their continuous and prolonged infusion function maximizes drug efficacy with minimal side effects. Contemporary pumps have sophisticated safety features, such as Dose Error Reduction Systems and alarms, that greatly diminish medication errors. In 2024, the American Cancer Society estimated more than 2 million new cancer diagnoses and 611,720 cancer deaths in the U.S., as outlined in their journal. Advances in portable ambulatory models will allow patients to be treated with chemotherapy at home, enhancing quality of life and lowering costs, while accommodating complex regimens and interfacing with electronic health records for enhanced clinical workflow.
End Use Insights
Hospitals were the market leaders and held a revenue share of 40.5% in 2024. Hospitals, and critical care, oncology, and pediatric wards specifically, are showing a great demand for accurate syringe infusion pumps to provide precise, controlled drug delivery of small-volume drugs vital for intricate treatments and reduction of errors. The wide-ranging clinical uses in treating diseases like cancer, cardiovascular disease, and postoperative pain, combined with high patient volumes and trained medical professionals who can handle sophisticated systems, further compel the absolute application of syringe pumps in hospitals for chemotherapy, pain relief, and anaesthesia.
Homecare is expected to expand with the highest CAGR of 8.7% during the forecast period. The growing incidence of chronic diseases requires long-term, accurate drug delivery, which demands homecare syringe infusion pumps to enable safe therapy at home. The transition of the healthcare system towards ambulatory and home healthcare, with the support of portable, easy-to-use pumps, increases patient convenience and lowers expenses. Advances in technology, such as connectivity and remote monitoring, enhance reliability and safety. Cost-effectiveness, mobility of patients, and positive regulatory and reimbursement assistance further drive the use of syringe pumps in home infusion.
Country Insights
U.S. Syringe Infusion Pumps Market Trends
The U.S. syringe infusion pumps market led North America with a revenue share of 81.5% in 2024. Based on CDC statistics in February 2024, an estimated 129 million Americans suffer from at least one chronic disease. The prevalence of chronic diseases is high and requires accurate medication delivery through syringe infusion pumps for diseases like cancer and diabetes. The CDC says that most chronic diseases can be avoided through the implementation of simple changes in lifestyle, including smoking, exercise, and healthy diet. Growth in the number of individuals with chronic diseases is one of the major drivers expected to drive the market during the forecast period.
In the opinion of CMS, the total healthcare spending expanded by 7.5% in 2023, helping adopt smart pumps with DERS and EHR integration. Product innovation, further boosted by FDA clearances and an increasing elderly population that necessitates long-term infusions, also fuels demand, along with increased home care and supportive regulation. The sheer size of America's hospital base also plays an important role in syringe pump adoption.
Canada Syringe Infusion Pumps Market Trends
Canada's syringe infusion pumps market is projected to grow significantly over the forecast period. The increasing prevalence of chronic diseases and a rise in surgical procedures and hospitalizations in Canada drive demand for precise syringe infusion pumps. Technological advancements, including smart features and EHR integration, enhance adoption. The growing preference for home healthcare and a favorable regulatory and reimbursement environment further support the wider utilization of these advanced infusion technologies.
Key North America Syringe Infusion Pumps Company Insights
Some key companies operating in the market include Baxter, B. Braun Medical Inc., Fresenius Kabi AG, ICU Medical, Inc., and Micrel Medical Devices SA. The market is intensely competitive, with key players utilizing technological innovations, FDA clearances, and strategic collaborations to maintain market leadership.
-
ICU Medical offers syringe infusion pumps such as the Medfusion 4000. This wireless pump ensures precise, small-volume drug delivery with versatile syringe compatibility and seamless connectivity. It is widely utilized in critical care, pediatrics, and anesthesia to enhance safety and efficiency.
-
Micrel Medical Devices SA supplies advanced syringe infusion pumps, such as the Micropump MP mlh+ Multi Syringe, designed for hospital and homecare settings. These portable, user-friendly, and reliable devices support therapies such as pain management and immunoglobulin infusion, catering to outpatient and long-term care needs.
Key North America Syringe Infusion Pumps Companies
- Baxter
- B. Braun Medical Inc.
- Fresenius Kabi AG
- ICU Medical, Inc.
- Micrel Medical Devices SA
- Boston Scientific Corporation
- BD
- Terumo Corporation
- Moog Inc.
- IRadimed Corporation
- CODAN Companies
- ACROMED
Recent Developments
-
In November 2024, Boston Scientific Corporation reported that it had signed an agreement to acquire Intera Oncology. The strategic buy is intended to broaden Boston Scientific's interventional oncology portfolio for the treatment of liver-dominant metastases with Intera's pump technology.
In August 2024, Innovative Health Sciences increased its commercial team to sell the Insignis Syringe Infusion System. Having gained FDA clearance in March 2024, this non-electric system provides accurate flow control for intravenous and subcutaneous administration in a variety of settings.
In April 2024, Baxter reported that the firm gained FDA clearance for its large volume infusion pump, Novum IQ, and Dose IQ Safety Software, combining both large volume and syringe infusion on a single platform.
North America Syringe Infusion Pumps Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 695.0 million |
|
Revenue forecast in 2030 |
USD 1.04 billion |
|
Growth rate |
CAGR of 8.4% from 2025 to 2035 |
|
Base year for estimation |
2024 |
|
Historical data |
2018 - 2023 |
|
Forecast period |
2025 - 2035 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2035 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
|
Segments covered |
Disease indication, end use, and country |
|
Regional scope |
North America |
|
Country scope |
U.S.; Canada; Mexico |
|
Key companies profiled |
Baxter; B. Braun Medical Inc.; Fresenius Kabi AG; ICU Medical, Inc.; Micrel Medical Devices SA; Boston Scientific Corporation; BD; Terumo Corporation; Moog Inc.; IRadimed Corporation; CODAN Companies; ACROMED |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
North America Syringe Infusion Pumps Market Report Segmentation
Disease Indication Outlook (Revenue, USD Million, 2018 - 2035)
-
-
Chemotherapy
-
Diabetes
-
Gastroenterology
-
Analgesia/Pain Management
-
Pediatrics/Neonatology
-
Hematology
-
Others
-
-
End Use Outlook (Revenue, USD Million, 2018 - 2035)
-
Hospitals
-
Homecare
-
Others (ASC, Nursing Homes, Rehabilitation Centers)
-
-
Country Outlook (Revenue, USD Billion, 2018 - 2035)
-
U.S.
-
Canada
-
Mexico
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy